Skip to content

Application of tubed versus tubeless enhanced recovery after surgery (ERAS) in robotic and laparoscopic gastrectomy: a double-arm, single-center clinical study

Application of tubed versus tubeless enhanced recovery after surgery (ERAS) in robotic and laparoscopic gastrectomy

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079013
Enrollment
Unknown
Registered
2023-12-22
Start date
2023-12-22
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

group 1:Robotic Gastric Cancer Tubeless Surgery
group 2:Robotic Gastric Cancer Intubation Surgery
group 3:Laparoscopic Gastric Cancer Tubeless Surgery
group 4:Laparoscopic Gastric Cancer Intubation Surgery

Sponsors

Second Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in this study and sign an informed consent form; 2. The patient's preoperative CT or ultrasound gastroscopy confirms that the lesion is gastric cancer, and there is no distant or lymph node metastasis. No gender limit, age = 18 and not exceeding 75 years old; 3. Expected survival time = 3 months; 4. ECOG score 0-1 points; 5. At least one measurable tumor lesion: on spiral CT, the long diameter = 10 mm and the short diameter of lymph nodes = 15 mm; For regular CT or physical examination, the maximum diameter must be = 20mm; 6. No major organ failure 7. No severe coagulation dysfunction 8. Individuals who can tolerate electronic gastroscopy examination

Exclusion criteria

Exclusion criteria: 1. Intestinal obstruction; 2. Intraoperative injury or combined resection of other organs such as pancreas and spleen; 3. Transfer to open surgery. 4. There is extensive adhesion in the peritoneal cavity; 5. There is obvious inflammation in the abdominal cavity; 6. There are high-risk factors for poor anastomotic healing, including anastomotic edema, ischemia, significant tension, and severe hypoalbuminemia; 7. Dysfunction of major organs such as the heart, kidneys, liver, and brain, and surgical risk classification of level III or above according to the American Society of Anesthesiologists (ASA); 8. cachexia, poor preoperative nutritional status, and a score of 3 or more on the nutritional status impairment score in the NRS2002 Nutrition Risk Screening Form; 9. Severe coagulation disorders; 10. Individuals with severe or uncontrolled cardiovascular and pulmonary diseases, or unstable vital signs caused by various reasons; 11. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
ASA Classification;NRS score;Operation time;Intraoperative blood loss;Postoperative VAS score;Postoperative Analgesic Dosing;Time of first ambulation after surgery;Postoperative ventilation time;Postoperative fluid intake time;Length of stay;

Secondary

MeasureTime frame
Age;Gender;Body mass index (bmi);Preoperative clinical staging;Number of lymph node removals;Hospitalization Costs;

Countries

China

Contacts

Public ContactHao Chen

Second Hospital of Lanzhou University

ery_chenh@lzu.edu.cn+86 150 0946 7790

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026